Transaction · 0001140361-25-005717

Venker Eric

Venker Eric, PRES, COO, reported an open-market or private sale at Roivant Sciences Ltd. involving 100000.000000 shares for an estimated $1065000.00. Reported holdings after the transaction were 896869.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SPRES, COO
ROIVRoivant Sciences Ltd.
Filing timeFeb 25
Trade dateFeb 20, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ROIV price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ROIV since 2025-02-25Filed 555 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001140361-25-005717
Common Shares
Transaction date
Feb 20, 2025
Filed Feb 25, 2025, 02:00 AM · 5d delay
Shares
100k sh
$1.06k per share
Estimated value
-$106M
Computed from shares × price
Holdings after
896k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Sale Repeat Seller
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & COO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Com…

  2. F2

    Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlemen…

  3. F3

    Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencem…

Original filing · 0001140361-25-005717
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ROIV